Lipocine develop branded products using its proprietary drug delivery technologies. They provide discovery and delivery support for challenging drugs. They issued 14 patents and corporate partnerships
Lipocine was founded in 1997 by Drs. William Higuchi (former Co-founder and Chairman of TheraTech, a drug delivery company) and Mahesh Patel (Pharmacia and Upjohn) to address the serious and pervasive issues related to delivery of challenging (poorly water soluble or poorly permeable, very water soluble) drugs through judicious utilization of LIPIDS to meet the unmet delivery needs. Lipocine is a pharmaceutical company leveraging its drug delivery technologies to commercialize innovative specialty pharmaceutical products and to provide delivery solutions for challenging drugs. Lipocine's business development strategy is to aggressively pursue alliances with leading pharmaceutical and biotechnology companies that have marketed products or compounds in development that would benefit from innovative drug delivery technology.
R&D
To view this information, you must subscribe to PL Intelligence.
Partnerships
To view this information, you must subscribe to PL Intelligence.
Deals
To view this information, you must subscribe to PL Intelligence.
Senior management
To view this information, you must subscribe to PL Intelligence.
Board of directors
To view this information, you must subscribe to PL Intelligence.
Contact details
To view this information, you must subscribe to PL Intelligence.
Head office
Lipocine
675 Arapeen Dr., Suite 202
Salt Lake City
Utah
84108 Utah